Qiang Tong Selected Research

Cytokines

1/2020	COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression.
4/2013	Synergistic enhancement of cancer therapy using a combination of fusion protein MG7-scFv/SEB and tumor necrosis factor alpha.
6/2012	Adipocyte expression of PU.1 transcription factor causes insulin resistance through upregulation of inflammatory cytokine gene expression and ROS production.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiang Tong Research Topics

Disease

22	Neoplasms (Cancer) 01/2022 - 11/2005
9	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2010
8	Parkinson Disease (Parkinson's Disease) 04/2021 - 01/2016
8	Carcinoma (Carcinomatosis) 02/2011 - 11/2003
7	Reperfusion Injury 01/2021 - 02/2015
6	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2008
5	Inflammation (Inflammations) 05/2022 - 01/2015
5	Type 2 Diabetes Mellitus (MODY) 10/2021 - 09/2013
5	Obesity 10/2021 - 12/2011
5	Myocardial Infarction 01/2019 - 01/2017
4	Body Weight (Weight, Body) 01/2022 - 10/2018
4	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019 - 01/2017
4	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 03/2015
3	Insulin Resistance 04/2022 - 12/2011
3	Esophageal Neoplasms (Esophageal Cancer) 07/2017 - 02/2011
3	Ankylosing Spondylitis 01/2015 - 10/2012
2	Pneumonia (Pneumonitis) 05/2021 - 01/2015
2	COVID-19 05/2021 - 01/2020
2	Anastomotic Leak 01/2021 - 01/2020
2	Ischemia 01/2021 - 02/2015
2	Esophageal Squamous Cell Carcinoma 12/2020 - 01/2018
2	Shock 01/2020 - 01/2020
2	Non-alcoholic Fatty Liver Disease 01/2020 - 01/2018
2	Ischemic Stroke 01/2019 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 01/2006
2	Infarction (Infarctions) 01/2019 - 01/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 10/2005
2	Glioma (Gliomas) 01/2017 - 08/2015
2	Brain Ischemia (Cerebral Ischemia) 01/2017 - 10/2008
2	Catalepsy 04/2016 - 01/2016
1	Fibrosis (Cirrhosis) 05/2022
1	Hyperglycemia 04/2022
1	Starvation 04/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2022
1	Diabetic Foot 01/2022
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2022
1	Overweight 10/2021

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2003
5	Sirtuin 3IBA 05/2022 - 01/2020
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2016
5	AntioxidantsIBA 01/2019 - 04/2016
5	Pharmaceutical PreparationsIBA 01/2018 - 04/2011
4	manganese tetrakis-(N-ethyl-2 pyridyl) porphyrinIBA 01/2020 - 01/2016
4	Neuroprotective AgentsIBA 01/2019 - 01/2016
4	EnzymesIBA 01/2018 - 02/2009
4	SurvivinIBA 02/2011 - 11/2005
3	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 01/2021
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2014
3	Indicators and Reagents (Reagents)IBA 01/2021 - 10/2010
3	CytokinesIBA 01/2020 - 06/2012
3	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 12/2016
3	ManganeseIBA 01/2019 - 06/2016
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 02/2015
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 04/2013
3	Carrier Proteins (Binding Protein)IBA 07/2012 - 10/2010
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2011 - 10/2005
2	LipidsIBA 10/2021 - 01/2018
2	Leucine-Rich Repeat ProteinsIBA 04/2021 - 01/2019
2	NucleotidesIBA 04/2021 - 01/2019
2	InflammasomesIBA 04/2021 - 01/2019
2	buyang huanwuIBA 01/2021 - 01/2019
2	Hypoglycemic Agents (Hypoglycemics)IBA 06/2019 - 04/2016
2	Small Interfering RNA (siRNA)IBA 01/2019 - 01/2014
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019 - 01/2016
2	Thioctic Acid (Lipoic Acid)IBA 01/2019 - 04/2016
2	GW 501516IBA 01/2019 - 01/2016
2	Sulfhydryl Compounds (Thiols)IBA 01/2019 - 12/2016
2	PorphyrinsIBA 01/2018 - 06/2016
2	schizandrin BIBA 01/2017 - 08/2015
2	Sirtuin 2IBA 01/2017 - 03/2013
2	alpha-SynucleinIBA 01/2017 - 01/2017
2	SynucleinsIBA 01/2017 - 04/2016
2	SirtuinsIBA 01/2017 - 01/2017
2	Plasminogen Activator Inhibitor 1IBA 12/2016 - 01/2016
2	RotenoneIBA 04/2016 - 01/2016
2	Transcription Factors (Transcription Factor)IBA 01/2014 - 06/2012
2	Liposomes (Liposome)IBA 01/2014 - 02/2009
2	Gemcitabine FDA Link 04/2011 - 02/2009
2	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 02/2011 - 05/2008
2	Messenger RNA (mRNA)IBA 10/2010 - 01/2006
2	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2009 - 12/2008
2	DNA (Deoxyribonucleic Acid)IBA 01/2009 - 11/2003
2	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 12/2008 - 10/2004
2	UbiquitinIBA 12/2008 - 10/2004
1	Mitogen-Activated Protein KinasesIBA 05/2022
1	palmitoleic acidIBA 04/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2022
1	Insulin Glargine (Lantus)FDA Link 10/2021
1	Glucagon-Like Peptides (Enteroglucagon)IBA 10/2021
1	AlbuminsIBA 10/2021
1	Exenatide (Byetta)FDA Link 10/2021

Therapy/Procedure

14	Therapeutics 01/2022 - 10/2004
7	Drug Therapy (Chemotherapy) 06/2016 - 04/2011
5	Radiotherapy 01/2018 - 02/2011
2	Fecal Microbiota Transplantation 08/2020 - 06/2019
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2019 - 01/2019
2	Transplantation 09/2013 - 11/2005
1	Surgical Amputation (Amputations) 01/2022